Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Affiliations
EULAR Congress 2011
European League Against Rheumatism (EULAR)
The European League Against Rheumatism (EULAR) is the organization which represents the patients, health professionals, and scientific societies of rheumatology of all the European nations. EULAR aims to promote, stimulate, and support the research, prevention, treatment, and rehabilitation of rheumatic diseases.
Where: London, UK
When: 25-28 May, 2011
Musculoskeletal Report and the content herein are neither sanctioned by, nor a part of, the European League Against Rheumatism
EULAR 2011 News
Outcomes Measures in AS to Determine Differential Capacity to Evaluate Treatment Efficiency in a 6 week RCT
May 31, 2011
An analysis was performed in order to determine how well single-item efficacy measures compare with multi-item efficacy measures in detecting treatment response to analgesic medications in patients with AS by creating a rank order of all common endpoints for AS...
Musculoskeletal Ultrasound (MSUS) Scanning of Patients with No Clinically Apparent Synovitis
May 30, 2011
This retrospective analysis looked at the diagnostic value of MSUS scanning in a group of patients with arthralgia but with no apparent joint synovitis on clinical examination...
The Economic Effects of Biologics when Managing Patients with RA
May 26, 2011
Biologic agents have made dramatic changes to management of rheumatoid arthritis, but it is still unclear if these drugs provide benefit from an economic aspect...
Early and Sustained Remission in Patients with PsA Treated with Golimumab: 2-Year Data from Phase III GO-REVEAL Trial
May 26, 2011
PsA patients treated with GLM resulted in long-term improvements in physical function, health-related quality of life, work productivity and reduction in healthcare utilization...
Belimumab and SLE
May 25, 2011
Three studies looked at the safety and efficacy of belimumab in patients with active SLE...
